James Chalmers, ERS 2020 – Bresocatib for Non-Cystic Fibrosis Bronchiectasis
We caught up with Professor James Chalmers (University of Dundee, Dundee, Scotland, UK) to discuss the recent phase 2, WILLOW clinical trial (NCT03218917), its results and what the future holds for bresocatib in the treatment of non-cystic fibrosis bronchiectasis. Questions Could you please give us a brief overview of non-cystic fibrosis bronchiectasis, its prevalence and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!